Port, Helena
Hausgaard, Cecilie Møller
He, Yi
Maksymowych, Walter P.
Wichuk, Stephanie
Sinkeviciute, Dovile
Bay-Jensen, Anne-Christine
Holm Nielsen, Signe
Funding for this research was provided by:
Innovationsfonden,Denmark (0153-00086B)
Article History
Received: 4 May 2023
Accepted: 30 November 2023
First Online: 7 December 2023
Competing interests
: HP, CMH, YH, DS, ACBJ and SHN are full-time employees at Nordic Bioscience A/S. YH, DS, ACBJ and SHN, hold stocks in Nordic Bioscience A/S. WPM has received consulting fees from AbbVie, Boehringer Ingelheim, Celgene, Galapagos, Gilead, Janssen, Lilly, Novartis, Pfizer, and UCB; and grant/research support from AbbVie, Novartis, Pfizer, and UCB; and is Chief Medical Officer of CARE Arthritis Limited. SW has no competing interest to declare. None of the authors received fees, bonuses, or other benefits for the work described in the manuscript.